[Cerebral glucose metabolism in schizophrenia. Studies using positron-emission tomography]
- PMID: 1670424
[Cerebral glucose metabolism in schizophrenia. Studies using positron-emission tomography]
Abstract
Several studies using positron emission tomography with 18F-fluorodeoxyglucose (18F-FDG) have revealed functional hypofrontality in schizophrenia. However, frontal hypometabolism is not consistently found and is not specific to schizophrenia. Basal ganglia glucose hypermetabolism related to neuroleptic treatment has been demonstrated. Methodological and clinical differences between studies are discussed in this paper.
Similar articles
-
Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.Am J Psychiatry. 1993 Sep;150(9):1325-36. doi: 10.1176/ajp.150.9.1325. Am J Psychiatry. 1993. PMID: 8352343
-
Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol.Am J Psychiatry. 1996 Jan;153(1):41-9. doi: 10.1176/ajp.153.1.41. Am J Psychiatry. 1996. PMID: 8540590
-
[No hypofrontality in schizophrenia demonstrated by positron emission tomography].Acta Psychiatr Belg. 1992 Sep-Oct;92(5):261-78. Acta Psychiatr Belg. 1992. PMID: 1345405 Review. French.
-
Positron emission tomography in asphyxiated infants. Preliminary studies of regional cerebral glucose metabolism using 18F-FDG.Acta Radiol Suppl. 1991;376:173. Acta Radiol Suppl. 1991. PMID: 1666770 No abstract available.
-
[18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].Nihon Rinsho. 1997 Jan;55(1):222-6. Nihon Rinsho. 1997. PMID: 9014454 Review. Japanese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical